Recently, RAD51C, essential for homologous recombination repair, has been reported to be a rare hereditary breast and ovarian cancer susceptibility gene and several pathogenic RAD51C mutations have been identified in BRCA1- and BRCA2-negative hereditary breast and ovarian cancer families (HBOC) [5]. Here, RAD51C is linked to ovarian cancer.